206 related articles for article (PubMed ID: 19198789)
1. [Autoimmune vasculitides. Standards and guidelines of EULAR and EUVAS].
Moosig F; Holle JU; Gross WL;
Internist (Berl); 2009 Mar; 50(3):298-309. PubMed ID: 19198789
[TBL] [Abstract][Full Text] [Related]
2. [Therapy of vasculitides: according to recommendations of the European League Against Rheumatism (EULAR) and European Vasculitis Study Group (EUVAS)].
Holle JU; Moosig F; Gross WL; ;
Internist (Berl); 2011 Jun; 52(6):671-81. PubMed ID: 21512793
[TBL] [Abstract][Full Text] [Related]
3. EULAR recommendations for the management of primary small and medium vessel vasculitis.
Mukhtyar C; Guillevin L; Cid MC; Dasgupta B; de Groot K; Gross W; Hauser T; Hellmich B; Jayne D; Kallenberg CG; Merkel PA; Raspe H; Salvarani C; Scott DG; Stegeman C; Watts R; Westman K; Witter J; Yazici H; Luqmani R;
Ann Rheum Dis; 2009 Mar; 68(3):310-7. PubMed ID: 18413444
[TBL] [Abstract][Full Text] [Related]
4. EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis.
Hellmich B; Flossmann O; Gross WL; Bacon P; Cohen-Tervaert JW; Guillevin L; Jayne D; Mahr A; Merkel PA; Raspe H; Scott DG; Witter J; Yazici H; Luqmani RA
Ann Rheum Dis; 2007 May; 66(5):605-17. PubMed ID: 17170053
[TBL] [Abstract][Full Text] [Related]
5. [New pathogenetic aspects in primary systemic vasculitides].
Lamprecht P
Internist (Berl); 2009 Mar; 50(3):291-7. PubMed ID: 19212730
[TBL] [Abstract][Full Text] [Related]
6. The systemic vasculitides.
LeRoy EC
Hosp Pract (Off Ed); 1992 Jul; 27(7):77-81, 85-6, 88. PubMed ID: 1385819
[TBL] [Abstract][Full Text] [Related]
7. [Vasculitis : EULAR/ACR guidelines with respect to the clinical cardiological routine].
Maisch B
Herz; 2015 Feb; 40(1):85-98. PubMed ID: 25676009
[TBL] [Abstract][Full Text] [Related]
8. 2018 Update of the EULAR recommendations for the management of large vessel vasculitis.
Hellmich B; Agueda A; Monti S; Buttgereit F; de Boysson H; Brouwer E; Cassie R; Cid MC; Dasgupta B; Dejaco C; Hatemi G; Hollinger N; Mahr A; Mollan SP; Mukhtyar C; Ponte C; Salvarani C; Sivakumar R; Tian X; Tomasson G; Turesson C; Schmidt W; Villiger PM; Watts R; Young C; Luqmani RA
Ann Rheum Dis; 2020 Jan; 79(1):19-30. PubMed ID: 31270110
[TBL] [Abstract][Full Text] [Related]
9. [Laboratory diagnostics of systemic autoimmune diseases. Part II: rheumatoid arthritis and vasculopathies].
Hartung K; Seelig HP
Z Rheumatol; 2007 May; 66(3):225-37; quiz 238. PubMed ID: 17429661
[TBL] [Abstract][Full Text] [Related]
10. [EULAR recommendations for the care of patients with small and medium-sized vessel vasculitides].
Reinhold-Keller E; de Groot K
Z Rheumatol; 2008 Dec; 67(8):704-6. PubMed ID: 19011879
[No Abstract] [Full Text] [Related]
11. Validation of the EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis by disease content experts.
Yates M; Watts R; Bajema I; Cid M; Crestani B; Hauser T; Hellmich B; Holle J; Laudien M; Little MA; Luqmani RA; Mahr A; Merkel P; Mills J; Mooney J; Segelmark M; Tesar V; Westman KWA; Vaglio A; Yalçındağ N; Jayne DR; Mukhtyar C
RMD Open; 2017; 3(1):e000449. PubMed ID: 28955487
[TBL] [Abstract][Full Text] [Related]
12. [Diagnosis and management of small vessel vasculitides].
Pettersson T; Karjalainen A
Duodecim; 2010; 126(12):1496-507. PubMed ID: 20617753
[TBL] [Abstract][Full Text] [Related]
13. Treatment of psoriatic arthritis: management recommendations.
Gossec L; Smolen JS
Clin Exp Rheumatol; 2015; 33(5 Suppl 93):S73-7. PubMed ID: 26471459
[TBL] [Abstract][Full Text] [Related]
14. EULAR recommendations for the management of large vessel vasculitis.
Mukhtyar C; Guillevin L; Cid MC; Dasgupta B; de Groot K; Gross W; Hauser T; Hellmich B; Jayne D; Kallenberg CG; Merkel PA; Raspe H; Salvarani C; Scott DG; Stegeman C; Watts R; Westman K; Witter J; Yazici H; Luqmani R;
Ann Rheum Dis; 2009 Mar; 68(3):318-23. PubMed ID: 18413441
[TBL] [Abstract][Full Text] [Related]
15. How to treat ANCA‑associated vasculitis: practical messages from 2016 EULAR/ERA‑EDTA recommendations.
Sznajd J; Mukhtyar C
Pol Arch Med Wewn; 2016 Oct; 126(10):781-788. PubMed ID: 27872452
[TBL] [Abstract][Full Text] [Related]
16. [ANCA-associated vasculitides. Classifying the disease and its activity according to EULAR/EUVAS recommendations].
Holle JU; Lamprecht P
Z Rheumatol; 2009 Feb; 68(1):75-80. PubMed ID: 19093126
[No Abstract] [Full Text] [Related]
17. [Rheumatology -- Part 3. Research news concerning epidemiology, diagnosis, and therapy of primary systemic vasculitides].
Lamprecht P; Ahmadi-Simab K; Gross WL; Hellmich B
Med Klin (Munich); 2006 Mar; 101(3):212-25. PubMed ID: 16648979
[TBL] [Abstract][Full Text] [Related]
18. Disease-specific quality indicators, guidelines, and outcome measures in vasculitis.
Mukhtyar C; Luqmani R
Clin Exp Rheumatol; 2007; 25(6 Suppl 47):120-9. PubMed ID: 18021517
[TBL] [Abstract][Full Text] [Related]
19. Allergy prevention.
Muche-Borowski C; Kopp M; Reese I; Sitter H; Werfel T; Schäfer T
Dtsch Arztebl Int; 2009 Sep; 106(39):625-31. PubMed ID: 19890407
[TBL] [Abstract][Full Text] [Related]
20. Position statement: UEMS- Section of Allergology and Clinical Immunology. European specialist care in allergology and clinical immunology in the new millennium.
Dubois AE; Palma-Carlos AG; Ewan PW; de Monchy JG
Allergy; 2000 Apr; 55(4):338-9. PubMed ID: 10782517
[No Abstract] [Full Text] [Related]
[Next] [New Search]
